Oxford Pharmascience Group Plc | Medicines made better

 

Investor Relations

AIM Rules


FSA Share Fraud Warning

Share fraud includes scams where investors are called out of the blue and offered shares that often turn out to be worthless or non-existent, or an inflated price for shares they own. These calls come from fraudsters operating in 'boiler rooms' that are mostly based abroad.

Please click here to access a copy of the new FSA Share Fraud Warning leaflet, published February 2012


The following information is disclosed in accordance with Rule 26 of the AIM Rules:


Shareholder Circulars

10 Mar 2017 Form of Proxy for AGM to be held on 19 June 2017

04 Mar 2016 Form of Proxy for AGM held on 22 June 2016

09 June 2015 Notice of General Meeting held on 24 June 2015

09 June 2015 Form of Proxy for General Meeting held on 24 June 2015

05 Mar 2015 Notice of AGM held on 24 June 2015

05 Mar 2015 Form of Proxy for AGM held on 24 June 2015

18 Jun 2014 Notice of AGM held on 18 June 2014

18 Jun 2014 Form of Proxy for AGM held on 18 June 2014

20 Mar 2013 Notice of AGM held on 12 June 2013

20 Mar 2013 Form of Proxy for AGM held on 12 June 2013

28 Feb 2013 Notice of General Meeting held on 19 March 2013

28 Feb 2013 Form of Proxy for General Meeting held on 19 March 2013

26 Nov 2012 Notice of General Meeting held on 12 December 2012

26 Nov 2012 Form of Proxy for General Meeting held on 12 December 2012

27 Mar 2012 Notice of Annual General Meeting held on 14 June 2012

Investment Strategy

See About Us

The names of the directors and biographical details

See Board

Directors' responsibilities & Committees

See Governance

Country of incorporation and main country of operation

Oxford Pharmascience Group Plc is incorporated in England & Wales (Registration Number 07036758) with England its main country of operation.

Current constitutional documents

Please click on the link below for the Articles of Association

Articles

Details of any other exchanges or trading platforms

The Company is not listed on any other exchanges or trading platforms.

Number of securities in issue

As at 15 October 2016 the number of shares in issue was 1,205,661,619.

Major Shareholders

As at 15 October 2016, shareholders holding more than 3% of the share capital of Oxford Pharmascience Group Plc were:

Holders > 3% Shares %
Woodford Investment Managers 401,597,920 33.31%
Mr R Griffiths 173,071,097 14.35%
David Norwood 105,938,633 8.79%
Marcelo Bravo 65,000,000 5.39%
Southern Fox Investments Ltd 51,000,000 4.23%
Octopus Investments 42,140,345 3.50%
Aviva Investors 37,964,329 3.15%
Mr R Quested 37,247,753 3.09%
Henderson Global Investors 37,000,000 3.07%
     

Shares not in Public hands

In the terms of the AIM Rules published July 2016 and insofar as it is aware, at 15 October 2016, 70.11% of the Company's AIM securities were not held in public hands.

UK City Code on Takeovers and Mergers

As an AIM traded UK registered company, Oxford Pharmascience Group Plc is subject to the UK City Code on Takeovers and Mergers legislation.

Details of any restrictions on the transfer of securities

There are no restrictions on the transfer of securities.

Company announcements

See Share Price & RNS

Admission document

Please click on the link below to access the Company's Admission Document dated 08 February 2010.

Admission document

Advisers

Nominated Adviser and Broker
N+1 Singer
One Bartholomew Lane
London
EC2N 2AX
Reporting Accountants and Auditors to the Company
Grant Thornton UK LLP
2 Broadfield Court
Sheffield
S8 0XF
Legal Advisers to the Company
Fladgate LLP
16 Great Queen Street
London
WC2B 5DG
Registrars
Neville Registrars Ltd
Neville House
18 Laurel Lane
Halesowen
W. Midlands
B63 3DA
Get Acrobat Reader

You will need Adobe Acrobat Reader to view PDF documents. To download it for free please click on the logo.

Page last updated: 10 March 2017